Jan Hillson

2.9k total citations · 1 hit paper
39 papers, 2.2k citations indexed

About

Jan Hillson is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Rheumatology. According to data from OpenAlex, Jan Hillson has authored 39 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 14 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Rheumatology. Recurrent topics in Jan Hillson's work include Monoclonal and Polyclonal Antibodies Research (14 papers), T-cell and B-cell Immunology (12 papers) and Systemic Lupus Erythematosus Research (11 papers). Jan Hillson is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), T-cell and B-cell Immunology (12 papers) and Systemic Lupus Erythematosus Research (11 papers). Jan Hillson collaborates with scholars based in United States, United Kingdom and Australia. Jan Hillson's co-authors include Roger M. Perlmutter, Harry W. Schroeder, Betty Diamond, David Wofsy, Aaron B. Kantor, Cynthia Merrill, L A Herzenberg, Eric H. Sasso, Nora G. Singer and Ellen M. Ginzler and has published in prestigious journals such as Science, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Jan Hillson

37 papers receiving 2.2k citations

Hit Papers

Early Restriction of the Human Antibody Repertoire 1987 2026 2000 2013 1987 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Early Restriction of the Human Antibody Repertoire
    1987 483 citations Harry W. Schroeder, Jan Hillson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Hillson United States 17 1.4k 1.0k 697 381 243 39 2.2k
R S Schwartz United States 22 1.4k 1.0× 1.3k 1.3× 576 0.8× 446 1.2× 341 1.4× 40 2.2k
Pojen P. Chen United States 27 887 0.6× 806 0.8× 1.1k 1.6× 303 0.8× 733 3.0× 59 2.2k
Lisa Willcocks United Kingdom 16 787 0.6× 359 0.4× 327 0.5× 352 0.9× 77 0.3× 40 1.6k
Paolo Durigutto Italy 21 715 0.5× 162 0.2× 658 0.9× 248 0.7× 421 1.7× 31 1.6k
Felipe Andrade United States 26 1.2k 0.8× 354 0.4× 1.3k 1.8× 828 2.2× 173 0.7× 56 2.9k
Christiane Werner‐Favre Switzerland 14 1.1k 0.8× 290 0.3× 263 0.4× 304 0.8× 167 0.7× 25 1.7k
B.A.W. de Jong Netherlands 12 748 0.5× 1.3k 1.3× 2.7k 3.8× 319 0.8× 382 1.6× 20 3.5k
Gisela Bonsmann Germany 25 692 0.5× 332 0.3× 1.3k 1.8× 171 0.4× 166 0.7× 72 2.2k
Ingrid Randen Norway 21 944 0.7× 967 1.0× 312 0.4× 219 0.6× 418 1.7× 37 1.6k
Pojen Chen United States 12 978 0.7× 281 0.3× 651 0.9× 462 1.2× 287 1.2× 14 1.7k

Countries citing papers authored by Jan Hillson

Since Specialization
Citations

This map shows the geographic impact of Jan Hillson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Hillson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Hillson more than expected).

Fields of papers citing papers by Jan Hillson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Hillson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Hillson. The network helps show where Jan Hillson may publish in the future.

Co-authorship network of co-authors of Jan Hillson

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Hillson. A scholar is included among the top collaborators of Jan Hillson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Hillson. Jan Hillson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramakrishnan, Aravind, Ann E. Woolfrey, Jan Hillson, et al.. (2021). Alpn-101 (ICOSL vIgD-Fc), a Dual Antagonist of the ICOS and CD28 Costimulatory Pathways, for Treatment of Steroid Refractory Acute GVHD (aGVHD): Case Report. Transplantation and Cellular Therapy. 27(3). S265–S266.
2.
3.
Ling, Leona, Jan Hillson, Renger G. Tiessen, et al.. (2018). M281, an Anti‐FcRn Antibody: Pharmacodynamics, Pharmacokinetics, and Safety Across the Full Range of IgG Reduction in a First‐in‐Human Study. Clinical Pharmacology & Therapeutics. 105(4). 1031–1039. 108 indexed citations
4.
5.
Fredlund, Paul, Jan Hillson, Todd Gray, et al.. (2015). Peginterferon Lambda-1a Is Associated with a Low Incidence of Autoimmune Thyroid Disease in Chronic Hepatitis C. Journal of Interferon & Cytokine Research. 35(11). 841–843. 5 indexed citations
6.
7.
Andersen, Henrik, Jeremy A. Freeman, Sean E. Doyle, et al.. (2013). Peginterferon Lambda-1a, a New Therapeutic for Hepatitis C Infection, from Bench to Clinic. Journal of Clinical and Translational Hepatology. 1(2). 116–24. 8 indexed citations
8.
Wofsy, David, Jan Hillson, & Betty Diamond. (2013). Comparison of Alternative Primary Outcome Measures for Use in Lupus Nephritis Clinical Trials. Arthritis & Rheumatism. 65(6). 1586–1591. 67 indexed citations
9.
Wofsy, David, Jan Hillson, & Betty Diamond. (2012). Abatacept for lupus nephritis: Alternative definitions of complete response support conflicting conclusions. Arthritis & Rheumatism. 64(11). 3660–3665. 119 indexed citations
10.
Mathias, Susan D., Ross D. Crosby, Martha Bayliss, et al.. (2011). PGI25 Chronic Hepatitis C (CHC) Related Flu-like Symptoms; Development of a Patient Report Outcome (PRO) Measure and Results from Pilot Efficacy Studies. Value in Health. 14(7). A396–A396. 1 indexed citations
11.
Gribben, JG, Joseph J. Stephenson, Nancy L. Bartlett, et al.. (2005). A phase II study of Xcellerated T Cells in patients with relapsed or refractory indolent non-Hodgkin’s lymphoma (NHL). Journal of Clinical Oncology. 23(16_suppl). 2510–2510. 1 indexed citations
12.
Magliano, Malgorzata, David Isenberg, & Jan Hillson. (2002). Pulmonary hypertension in autoimmune rheumatic diseases: Where are we now?. Arthritis & Rheumatism. 46(8). 1997–2009. 35 indexed citations
13.
Moreland, Larry W., Kevin R. King, Michael Weisman, et al.. (2001). Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis. Arthritis Research & Therapy. 3(4). 247–52. 41 indexed citations
14.
Hillson, Jan & Daniel E. Fürst. (2000). Rofecoxib. Expert Opinion on Pharmacotherapy. 1(5). 1053–1066. 17 indexed citations
15.
Hillson, Jan & Daniel E. Fürst. (1997). PHARMACOLOGY AND PHARMACOKINETICS OF METHOTREXATE IN RHEUMATIC DISEASE. Rheumatic Disease Clinics of North America. 23(4). 757–778. 36 indexed citations
16.
Hillson, Jan, et al.. (1993). The structural basis of germline-encoded VH3 immunoglobulin binding to staphylococcal protein A.. The Journal of Experimental Medicine. 178(1). 331–336. 111 indexed citations
17.
Hillson, Jan, et al.. (1992). Emerging human B cell repertoire. Influence of developmental stage and interindividual variation. The Journal of Immunology. 149(11). 3741–3752. 51 indexed citations
18.
Olee, T, Pei–Ming Yang, K A Siminovitch, et al.. (1991). Molecular basis of an autoantibody-associated restriction fragment length polymorphism that confers susceptibility to autoimmune diseases.. Journal of Clinical Investigation. 88(1). 193–203. 91 indexed citations
19.
Schroeder, Harry W., Jan Hillson, & Roger M. Perlmutter. (1990). Structure and evolution of mammalian VH families. International Immunology. 2(1). 41–50. 156 indexed citations
20.
Hillson, Jan & Roger M. Perlmutter. (1990). Autoantibodies and the Fetal Antibody Repertoire. International Reviews of Immunology. 5(3-4). 215–229. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R S Schwartz Breakdown of academic impact, for papers by Pojen P. Chen Breakdown of academic impact, for papers by Lisa Willcocks Breakdown of academic impact, for papers by Paolo Durigutto Breakdown of academic impact, for papers by Felipe Andrade Breakdown of academic impact, for papers by Christiane Werner‐Favre Breakdown of academic impact, for papers by B.A.W. de Jong Breakdown of academic impact, for papers by Gisela Bonsmann Breakdown of academic impact, for papers by Ingrid Randen Breakdown of academic impact, for papers by Pojen Chen
Rankless by CCL
2026